New breast marker aims to make surgery smoother for patients and surgeons
NCT ID NCT06294574
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 32 times
Summary
This study compares a new breast biopsy site marker (HydroMARK Plus) with the standard marker to see if it is easier for surgeons to retrieve during surgery. About 150 women with breast cancer who need surgery will take part. The goal is to improve the marker removal process and surgeon satisfaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Kirklin Clinic
RECRUITINGBirmingham, Alabama, 35249, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HydroMARK Plus clip (a breast biopsy site marker device)
What this could lead to
If successful, surgeons may find it easier to locate and remove breast biopsy markers during surgery, potentially improving surgical precision and patient experience.
What could go wrong
This is a small, early-stage study (150 participants) comparing two markers. The new marker may not be easier to retrieve, and results may not apply to all patients or settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.